SARS-CoV-2+Influenza A/B Antigen Assay


In Stock & Ready to Ship

  • Format: 25 tests per kit
  • Swab Collection Method: Nasopharyngeal, Anterior Nasal, Oropharyngeal
  • Results: 20 minutes



SARS-CoV-2+Influenza A and B Antigen Assay Kit is a rapid visual immunoassay for the qualitative, presumptive detection of influenza A and B viral antigens and SARS-CoV-2 Antigen form Nasal swabs and nasopharyngeal swab specimens. The test is intended for use as an aid in the rapid differential detection of acute influenza type A and type B virus and SARS-CoV-2 infection.

For Research Use Only. Not for use in Diagnostic Procedures.

You may also like…

SARS-CoV-2 Antibody Assay


This is an Antibody Serologic Assay (SCSA) for SARS-CoV-2. 


This test has not been reviewed by the FDA.


The SARS-CoV-2 Antibody rapid test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-SARS CoV-2 antibody which may be found in samples such as serum, plasma, whole blood or cell culture media. This product is suitable for screening for the presence of SARS-CoV-2 reactive antibody in a Research Use Only Fashion.

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.

Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.